Other News To Note
• BiondVax Pharmaceuticals Ltd., of Nes Ziona, Israel, entered a partnership with Warren, N.J.-based MonoSol Rx LLC to develop an oral film formulation of BiondVax's universal flu vaccine, M-001, using MonoSol Rx's PharmFilm delivery platform. The collaboration will include studies using PharmFilm technology to investigate the activity and formulation of the influenza vaccine when delivered via an oral film. Financial terms were not disclosed.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST